clopidogrel has been researched along with Disseminated Intravascular Coagulation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anil Kumar, S; Othman, M; Tafazoli, A | 1 |
| Dubin, I; Schattner, A; Uliel, L | 1 |
| Keck, J; Lennon, R; Yosay, J | 1 |
| Alex, M; Eckly, A; Engelmann, B; Gachet, C; Klocke, A; Leon, C; Moosbauer, C; Morgenstern, E; Spannagl, M | 1 |
1 review(s) available for clopidogrel and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
Topics: Abciximab; Acute Disease; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Fibrinolytic Agents; Humans; Lung; Platelet Activation; Pulmonary Embolism; SARS-CoV-2; Treatment Outcome | 2022 |
3 other study(ies) available for clopidogrel and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Endoleak-induced DIC presenting as massive chest wall haematoma in a patient on dual antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Disseminated Intravascular Coagulation; Dual Anti-Platelet Therapy; Endoleak; Hematoma; Humans; Male; Platelet Aggregation Inhibitors; Thoracic Wall | 2020 |
Spontaneous hematomas.
Topics: Aspirin; Clopidogrel; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Hematoma; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 2013 |
Platelet ADP receptors contribute to the initiation of intravascular coagulation.
Topics: Adult; Animals; Blood Coagulation; Blood Platelets; Clopidogrel; Collagen; Disease Models, Animal; Disseminated Intravascular Coagulation; Factor Xa; Humans; Leukocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Immunoelectron; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Reference Values; Thrombin; Thromboplastin; Thrombosis; Ticlopidine | 2004 |